(Q67984627)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1900552%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

title

OKT3 first-dose reaction: association with T cell subsets and cytokine release (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1900552%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

author name string

R S Gaston

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1900552%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

M H Deierhoi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1900552%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

T Patterson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1900552%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

E Prasthofer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1900552%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

B A Julian

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1900552%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

W H Barber

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1900552%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

D A Laskow

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1900552%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

A G Diethelm

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1900552%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

J J Curtis

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1900552%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

language of work or name

English

0 references

publication date

1 January 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1900552%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1900552%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1900552%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1900552%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

page(s)

141-148

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1900552%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/ki.1991.18

20 September 2019

exact match

0 references

cites work

A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.18

7 January 2021

A comparison of OKT3 monoclonal antibody and corticosteroids in the treatment of acute renal allograft rejection.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.18

7 January 2021

Early use of OKT3 monoclonal antibody in renal transplantation to prevent rejection.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.18

7 January 2021

Muromonab CD3. A review of its pharmacology and therapeutic potential

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.18

7 January 2021

Complications and monitoring of OKT3 therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.18

7 January 2021

OKT3-induced cytokine release attenuation by high-dose methylprednisolone

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.18

7 January 2021

Evolving use of OKT3 monoclonal antibody for treatment of renal allograft rejection

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.18

7 January 2021

OKT3: First-dose safety and success

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.18

7 January 2021

Effects of in vivo administration of monoclonal antibodies specific for human T cell subpopulations on the immune system in a rhesus monkey model

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.18

7 January 2021

Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.18

7 January 2021

Detection of circulating tumor necrosis factor after endotoxin administration.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.18

7 January 2021

The role of cachectin/TNF in endotoxic shock and cachexia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.18

7 January 2021

Release of tumor necrosis factor, interleukin-2, and gamma-interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.18

7 January 2021

Systemic reaction to the anti-T-cell monoclonal antibody OKT3 in relation to serum levels of tumor necrosis factor and interferon-gamma [corrected]

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.18

7 January 2021

Induction of circulating tumor necrosis factor (TNF alpha) as the mechanism for the febrile response to interleukin-2 (IL-2) in cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.18

7 January 2021

Tumor necrosis factor and disease severity in children with falciparum malaria.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.18

7 January 2021

The effects of tumor necrosis factor and their selective inhibition by ibuprofen

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.18

7 January 2021

Tumor necrosis factor causes increased pulmonary permeability and edema. Comparison to septic acute lung injury

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.18

7 January 2021

Murine anti-CD3 monoclonal antibody induces potent cytolytic activity in both T and NK cell populations

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.18

7 January 2021

Does OKT3 monoclonal antibody react with an antigen-recognition structure on human T cells?

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.18

7 January 2021

Monoclonal antibody specificity: Orthoclone OKT3 T-cell blocker

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.18

7 January 2021

Fc receptors on monocytes cause OKT3-treated lymphocytes to internalize T3 and to secrete IL-2

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.18

7 January 2021

Effect of immunosuppressants on OKT3 associated T cell activation: clinical implications.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.18

7 January 2021

Lymphokine and nonlymphokine mRNA levels in stimulated human T cells. Kinetics, mitogen requirements, and effects of cyclosporin A

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.18

7 January 2021

Inhibition of cytokine production by cyclosporin A and transforming growth factor beta

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.18

7 January 2021

The effects of cyclosporin A on the immune system

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.18

7 January 2021

Anti-CD3 antibody for autoimmune disease, a cautionary note

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.18

7 January 2021

Production of tumor necrosis factor/cachectin by human T cell lines and peripheral blood T lymphocytes stimulated by phorbol myristate acetate and anti-CD3 antibody

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.18

7 January 2021

Cytotoxicity mediated by soluble antigen and lymphocytes in delayed hypersensitivity. 3. Analysis of mechanism

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.18

7 January 2021

Dissection of the role of macrophages in triggering T lymphocytes for interleukin 2 production by monoclonal antibody OKT3

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.18

7 January 2021

Tumor necrosis factor stimulates prostaglandin production and cyclic AMP levels in rat cultured mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.18

7 January 2021

Interleukin 1 and tumor necrosis factor synergistically stimulate prostaglandin synthesis and phospholipase A2 release from rat renal mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.18

7 January 2021

Identifiers

DOI

10.1038/KI.1991.18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1900552%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

20 September 2019

0 references

1 reference